Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication <i>in vitro</i> : Clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant

Ruth A. Karron, Deborah A. Buonagurio, Alice Georgiu, Stephen S. Whitehead, Jean Adamus, Mary Lou Clements‐Mann, Denos O. Harris, Valerie B. Randolph, Stephen A. Udem, Brian R. Murphy,

Proceedings of the National Academy of Sciences · 1997 · 416 citations · 21 references

DOIFull text

Open access

Concepts

Abstract

A live, cold-passaged (cp) candidate vaccine virus, designated respiratory syncytial virus (RSV) B1 cp-52/2B5 (cp-52), replicated efficiently in Vero cells, but was found to be overattenuated for RSV-seronegative infants and children. Sequence analysis of reverse-transcription-PCR-amplified fragments of this mutant revealed a large deletion spanning most of the coding sequences for the small hydrophobic (SH) and attachment (G) proteins. Northern blot analysis of cp-52 detected multiple unique read-through mRNAs containing SH and G sequences, consistent with a deletion mutation spanning the SH:G gene junction. Immunological studies confirmed that an intact G glycoprotein was not produced by the cp-52 virus. Nonetheless, cp-52 was infectious and replicated to high titer in tissue culture despite the absence of the viral surface SH and G glycoproteins. Thus, our characterization of this negative-strand RNA virus identified a novel replication-competent deletion mutant lacking two of its three surface glycoproteins. The requirement of SH and G for efficient replication in vivo suggests that selective deletion of one or both of these RSV genes may provide an alternative or additive strategy for developing an optimally attenuated vaccine candidate.

References

21